土耳其住院患者对药物监测的知识,态度和实践:一个横截面研究
Tansel Bekiroglu Ergun1, Mine Akben1, Yusuf Ergun2
1Kahramanmaras Sutcu Imam University, School of Health Sciences, Department of Nursing, Kahramanmaras, Turkey.
Pakistan journal of pharmaceutical sciences
|February 28, 2026
概括
患者报告药物不良反应 (ADR) 对药物安全至关重要. 然而,土耳其住院患者对药物监测的知识和实践不足,阻碍了有效的副作用报告和药物安全性改进.
科学领域:
- 药监和药物安全 药监和药物安全
- 患者报告的结果
- 公共卫生研究 公共卫生研究
背景情况:
- 药物不良反应 (ADRs) 的低报告是全球药监系统面临的重大挑战.
- 改善患者对药物监测的贡献需要了解他们的知识,态度和做法.
- 之前对土耳其卫生专业人员参与的评估表明,需要进一步调查消费者参与.
研究的目的:
- 评估土耳其一所大学医院的住院患者对药物监测的知识,态度和做法.
- 确定患者参与报告药物不良反应的障碍和促进因素.
- 为提高患者参与药物监督活动的战略提供信息.
主要方法:
- 一项使用面对面调查问卷对260名住院患者进行的观察性,横截面研究.
- 调查问卷评估了与药监有关的人口统计数据,知识 (15项),态度/做法 (9项).
- 统计分析包括曼-惠特尼U,克鲁斯卡尔-沃利斯和恩-西达克测试用于数据比较.
主要成果:
- 住院患者对药监知识的评分显著低 (平均1.38/15).
- 虽然94.62%的人承认副作用,但只有6.92%的人听说过药监督或土耳其药监督中心.
- 在那些了解该中心的人中,只有11.11%的人报告了ADR;42%的人经历了ADR,大多数人咨询医生而不是报告.
- 对副作用的首选干预措施是停止使用药物 (60.75%).
结论:
- 土耳其住院患者表现出对药物监督的知识,态度和做法不足.
- 迫切需要实施有针对性的教育计划,以刺激患者报告ADR.
- 提高患者意识和参与度对于改善自发性ADR报告率和促进主动药物安全措施至关重要.
相关概念视频
01:19Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
229
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
229
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
192
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
192
01:26Pharmaceutical Poisoning: Potential Scenarios
39
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
39
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
273
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
273
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
765
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
765